Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Skull Base Neoplasms 1Patients Who Are Treated With Tyrosine Kinase Inhibitors 1Anosmia 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Olfactory Training × Clear all
NCT05912881 2026-02-18

Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery

Johns Hopkins University

Phase NA Completed
41 enrolled

Anosmia, Skull Base Neoplasms

NCT07258589 2025-12-02

TASTY-training

University Medical Center Groningen

Phase NA Recruiting
90 enrolled

Patients Who Are Treated With Tyrosine Kinase Inhibitors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡